about us

Long-lasting Zyprexa gets FDA nod

Lurasidone Effective in Adult Schizophrenia With Few Adverse Metabolic Effects

INVEGA(R) SUSTENNA(TM) Statistically Similar to RISPERDAL(R) CONSTA(R) Long-Acting Injection

Fanapt(TM) Launches in the United States, January 11 2010

Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Historical perspective on antipsychotic long-acting injections

NAMI's Survey on Depression: Summary of Findings Gaps & Guideposts

You Tube Video on What is Schizophrenia: by Dr. Ken Duckworth

Visit the Mental Health Journal Message Board

CONSUMERS/
FAMILIES

PROFESSIONALS

Contact Information:

Tom Albert, RPh
President of Clinical Services
toma@promentisus.com

John Bouloubasis
COO
johnb@promentisus.com

Promentis Phone Number
330-687-0807

Latest Industry News